M. Chéron

发表

Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.

G. Ponchel, P. Legrand, D. Duchěne, 2001, International journal of pharmaceutics.

Cochleate formulations of amphotericin b designed for oral administration using a naturally occurring phospholipid.

A. Angelova, V. Nicolas, G. Barratt, 2021, International journal of pharmaceutics.

Interaction of amphotericin B with polymeric colloids: A spectroscopic study

J. Irache, P. Legrand, G. Barratt, 1998 .

Development of oil-in-water microemulsions for the oral delivery of amphotericin B.

G. Barratt, A. E. Silva, E. Egito, 2013, International journal of pharmaceutics.

Improved formulation of W/O/W multiple emulsion for insulin encapsulation. Influence of the chemical structure of insulin

B. Lacour, C. Vauthier, V. Rosilio, 2004 .

W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetic rats

J. Grossiord, A. Silva-Cunha, F. Puisieux, 1998 .

Development of antileishmanial lipid nanocomplexes.

G. Barratt, P. Loiseau, P. Chaminade, 2014, Biochimie.

Quantitative structure-activity relationships in amphotericin B derivatives.

J. Grzybowska, E. Borowski, J. Mazerski, 1988, Biochemical pharmacology.

Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism

E. Abachin, E. Guérot, M. Simonet, 1994, Journal of clinical microbiology.

Effect of high pressure homogenization on the structure and the interfacial and emulsifying properties of β-lactoglobulin.

F. Agnely, V. Rosilio, I. le Potier, 2018, International journal of pharmaceutics.

Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and nonaromatic heptaene antibiotics (vacidin A and amphotericin B).

J. Bolard, J. Mazerski, M. Chéron, 1984, Biochemical pharmacology.

Community-acquired Clostridium difficile infections in emergency departments.

F. Bouchand, C. Duran, A. Dinh, 2016, Medecine et maladies infectieuses.

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

J. Irache, C. Gamazo, P. Legrand, 2003, The Journal of antimicrobial chemotherapy.

Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions.

A. Bochot, J. Grossiord, D. Duchěne, 2003, International journal of pharmaceutics.

First enantioselective total synthesis and configurational assignments of suberosenone and suberosanone as potential antitumor agents.

J. Dubois, F. Dumas, I. Chataigner, 2015, Chemical communications.

Characteristics of o/w emulsions containing lipophilic molecules with cyclodextrins as emulsifiers

A. Bochot, J. Grossiord, D. Duchěne, 2001 .

Design and evaluation of an original o/w/o multiple emulsion containing natural cyclodextrins as the emulsifier

A. Bochot, J. Grossiord, D. Duchěne, 1999 .

Study of β-cyclodextrin and ethylated β-cyclodextrin salbutamol complexes, in vitro evaluation of sustained-release behaviour of salbutamol

D. Duchěne, D. Wouessidjewe, M. Chéron, 1996 .

Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.

P. Legrand, J. Bolard, M. Chéron, 1997, Journal of drug targeting.

Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin.

G. Ponchel, K. Bouchemal, J. Gallard, 2011, International journal of pharmaceutics.

In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid

R. Farinotti, Claude Carbón, P. Yeni, 1994, Antimicrobial Agents and Chemotherapy.

Modulation of polyene antibiotics self-association by ions from the Hofmeister series.

S. Schreier, E. Borowski, J. Bolard, 2006, Biochimica et biophysica acta.

Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index

J. Bolard, C. Petit, F. Gaboriau, 1997, Antimicrobial agents and chemotherapy.

Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin B.

J. Bolard, F. Gaboriau, M. Chéron, 1997, Biophysical chemistry.

Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.

J. Bolard, C. Petit, F. Gaboriau, 2003, The Journal of antimicrobial chemotherapy.

The Contribution of Raman Scattering to the Fluorescence of the Polyene Antibiotic Amphotericin B

J. Cleary, J. Bolard, M. Chéron, 2011, Journal of Fluorescence.

Does fluorescence spectroscopy detect dimers of the polyene antibiotic amphotericin B?

J. Bolard, M. Chéron, 2003, Journal of photochemistry and photobiology. B, Biology.

New lipid formulation of amphotericin B: spectral and microscopic analysis.

P. Legrand, G. Barratt, A. Gulik, 2004, Biochimica et biophysica acta.

Interaction of amphotericin B with polymeric colloids: 2. Effect of poloxamer on the adsorption of amphotericin B onto poly(ϵ-caprolactone) nanospheres

J. Irache, P. Legrand, G. Barratt, 1998 .

Association of the polyene antibiotic amphotericin B with phospholipid vesicles: perturbation by temperature changes.

J. Bolard, M. Chéron, 1982, Canadian journal of biochemistry.

In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.

J. Bolard, C. Petit, F. Gaboriau, 1998, The Journal of antimicrobial chemotherapy.

Modulation of the polyene antibiotic amphotericin B selective toxicity by pH change of the stock solutions

M. Benyoucef, M. Chéron, S. Belbraouet, 2008 .

N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.

J. Bolard, J. Mazerski, M. Chéron, 2000, Acta biochimica Polonica.

Inhibition by Cu2+ of amphotericin B induced lysis of erythrocytes

J. Bolard, M. Chéron, J. Brajtburg, 1984, FEBS letters.

Lymph node infection by Trichomonas tenax: report of a case with co-infection by Mycobacterium tuberculosis.

M. Chéron, C. Duboucher, F. Beaufils, 2000, Human pathology.

Triple helix-tetraplex equilibrium for G-rich oligonucleotide N3′→P5′ phosphoramidates: role of molecular concentration and counterions

E. Taillandier, J. Liquier, M. Chéron, 2005 .

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.

M. Chéron, A. Boisivon, M. Leneveu, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.

C. Vauthier, M. Besnard, M. Chéron, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen.

Ruxandra Gref, Patrick Couvreur, P. Couvreur, 2009, Biomacromolecules.

Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.

M. Chéron, P. Mornet, P. Jouve, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Development of oil-in-water microemulsions for the oral delivery of amphotericin B.

G. Barratt, A. E. Silva, E. Egito, 2013, International journal of pharmaceutics.